Compare CVS Health Corp (CVS) vs GraniteShares 2x Long NVDA Daily ETF (NVDL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs GraniteShares 2x Long NVDA Daily ETF — how do they compare? CVS Health Corp trades at $86.27 (market cap $112.29B), while GraniteShares 2x Long NVDA Daily ETF trades at $37.7 (market cap $3.56B). The key difference: CVS Health Corp is far larger — about 31.5× GraniteShares 2x Long NVDA Daily ETF's market cap, and CVS Health Corp pays a 3.03% dividend while GraniteShares 2x Long NVDA Daily ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and GraniteShares 2x Long NVDA Daily ETF for 15 Days on average.
| CVS | NVDL | |
|---|---|---|
Market Cap | $112.29B | $3.56B |
Volume | 7,763,676 | 9,740,643 |
Sector | Health | Leveraged / Inverse |
52-Week High | $110.60 | $43.02 |
52-Week Low | $70.08 | $21.76 |
Typical Hold Time | 83 Days | 15 Days |
Enterprise Value | $174.64B | — |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats in Q1 and Q2 2026, alongside steady revenue growth to $402.07B in 2025, highlight operational strength. The stock's valuation appears attractive with a P/E of 23.17 and P/S of 0.27, while a consensus price target of $111.20 suggests significant upside potential. Positive news includes Aetna's 2027 Medicare plan enhancements and a declared quarterly dividend.
The outlook for CVS remains positive, driven by earnings momentum and strategic initiatives in healthcare services. Key risks include reimbursement pressures and regulatory scrutiny, but Wall Street's 85% buy rating and institutional interest underscore confidence. Investors should weigh the stock's growth prospects against margin volatility and debt levels, with the current price offering a favorable entry point relative to targets.
NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $39.57, down 1.49% amid mixed technical signals. While moving averages show strong bullish momentum with 13 buy signals, oscillators remain neutral and short-term RSI readings suggest overbought conditions near 75. The ETF tracks Nvidia's performance with 2x daily leverage, benefiting from Nvidia's continued AI leadership and recent earnings beats, though it has underperformed the underlying stock over the past year with 17.21% gains versus NVDA's 22.21%.
The outlook remains cautiously optimistic given Nvidia's dominant AI position and technical breakout potential, but leveraged ETF structure introduces volatility decay risks. Key resistance sits at $41 with support at $39. Investors face concentration risk in the single-stock ETF approach while benefiting from Nvidia's $6 trillion market cap target narrative and strong institutional interest in AI infrastructure plays.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About GraniteShares 2x Long NVDA Daily ETF
NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →
